WFRF:(Aschan M. M.)
Search: WFRF:(Aschan M. M.) > A phase II trial of...
- 39 of 85
- Previous record
- Next record
- To hitlist
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning
-
- Hassan, M (author)
- Karolinska Institutet
-
- Nilsson, C (author)
- Karolinska Institutet
-
- Hassan, Z (author)
- Karolinska Institutet
- show more...
- Gungor, T (author)
- Aschan, J (author)
- Hentschke, P (author)
- Eber, S (author)
- Seger, R (author)
- show less...
- (creator_code:org_t)
- 2002-12-12
- 2002
- English.
- In: Bone marrow transplantation. - : Springer Science and Business Media LLC. - 0268-3369 .- 1476-5365. ; 30:12, s. 833-841
- Journal article (peer-reviewed)
Subject headings
Close
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Bone marrow transplantation (Search for host publication in LIBRIS)
To the university's database
- 39 of 85
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hassan, M
- Nilsson, C
- Hassan, Z
- Gungor, T
- Aschan, J
- Winiarski, J
- show more...
- Hentschke, P
- Ringden, O
- Eber, S
- Seger, R
- Ljungman, P
- show less...
- Articles in the publication
- Bone marrow tran ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
